Epilepsy and Seizure News
Neurofeedback News
What Is Neurofeedback Therapy And How Does It Work? -
Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...
Rewiring Your Brain: Neurofeedback Goes Mainstream -
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Will Strahl walked up to my door with a massive black briefcase in his ...
Neuron Connect Expands Access to Advanced Brain Health Technology Through Strategic Healthcare Partnerships -
Scottsdale, AZ, USA, July 15th, 2026, FinanceWireThe Arizona-based company is helping physicians integrate brain mapping, ...
What Is Neurofeedback? -
Whenever I mention that neurofeedback helped me regain my life after my multiple brain injuries — or that I’m now a neurofeedback provider — the first reaction is to ask me, what is neurofeedback? I’m ...
I Tried Direct Neurofeedback and the Results Surprised Me -
Transhumanism—the movement of using science and technology to improve the human being—covers many different fields of research. There are exoskeleton suits to help the disabled; there are stem cell ...
Medical News Today
PubMed
Multidisciplinary management and nursing care for pediatric patients with febrile infection-related epilepsy syndrome in the acute phase: A case series -
RATIONALE: This case series discusses the nursing care and clinical outcomes of 3 pediatric patients with febrile infection-related epilepsy syndrome (FIRES) and acute-phase complications, focusing on critical care interventions such as seizure management, respiratory support, and nutritional therapy.
Beyond seizures: understanding adaptive functioning in drug-resistant epilepsy in patients undergoing palliative surgery -
PURPOSE: To evaluate clinical predictors of adaptive functioning in pediatric patients with drug-resistant epilepsy (DRE) and the impact of corpus callosotomy and vagus nerve stimulation (VNS) using the Vineland Adaptive Behavior Scales (VABS) during long-term follow-up.
Antiseizure properties of new selenobenzimidazole derivatives: A pre-clinical study in a neonatal model of epilepsy -
This study aimed to evaluate the anti-seizure potential of new selenobenzimidazole compounds and identify their potential molecular targets. The primary research question was whether these novel benzimidazolic derivatives could effectively control seizures and mitigate their severity. The research combined an in vivo animal model of neonatal epilepsy with in silico molecular target prediction. ...
First-episode psychosis and mood disorder onset in individuals with epilepsy -
BACKGROUND: Psychiatric disorders represent a major burden for patients with epilepsy (PwE). This study examined how demographic, epilepsy-related, and clinical risk factors contribute to the onset of mood and psychotic disorders in epilepsy.
Cenobamate in older adults with drug-resistant epilepsy: Real-world tolerability, efficacy, and predictors of discontinuation -
CONCLUSION: CNB is effective and generally well-tolerated in older adults, with most reaching therapeutically meaningful doses. However, an elevated comorbidity burden and advancing age (≥70 years) increase the risk of discontinuation due to adverse effects, underscoring the need for individualized, cautious titration in this vulnerable population.
Deep brain stimulation in pediatric drug-resistant epilepsy: Implications for the developing connectome -
Epilepsy is increasingly recognized as a disorder of brain networks, and intracranial neuromodulation has emerged as a therapeutic strategy for individuals with drug-resistant epilepsy (DRE). In pediatric populations, however, ongoing brain development raises important questions regarding safety, efficacy, and long-term consequences of chronic neuromodulation. In this review, we examine the eme...
Science Daily